Given Symbion's unsuccessful attempt to purchase the pathology...

Given Symbion's unsuccessful attempt to purchase the pathology business of Primary Healthcare surely the next logical step is to make an offer for Healthscope's entire business (or maybe just their path business)??? CEO of Symbion knows the hospitals owned by Halthscope very well (he owned them previously as CEO of Affinity). AFR has commented a few times that Symbion could be looking at Healthscope and there is a rumour in the marketplace. Would also be EPS positive for Symbion as Healthscope is still cheap on a PE basis compared to the other health stocks and price has already increased last few months unlike the other health stocks)

Wish I had of bouth them under $4 but still think they are a buy at these levels.

Watch this space!